Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Oral fingolimod (FTY720) therapy reduces blood brain barrier breakdown, microglial activation, and leukocyte recruitment in a focal DTH model of multiple sclerosis

Bibliographic Details
Main Authors: Anthony, D, Sibson, N, Losey, P, Piani, D, Leppert, D
Format: Conference item
Published: 2009

Similar Items